The phosphatidylinositol 3′-kinase (PI3K) signaling pathway is one of the most frequently altered pathways in human cancers that impacts major hallmarks of malignancies [1] and remarkably contributes to cancer initiation [2, 3], progression, metastasis, metabolism, and cell survival [4–8]. The gene discussed is PIK3CA; the disease is cancer.